Versant Venture Management, LLC has filed its 13F form on May 03, 2024 for Q1 2024 where it was disclosed a total value porftolio of $71.7 Million distributed in 7 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Crispr Therapeutics Ag with a value of $34M, Repare Therapeutics Inc. with a value of $12.5M, Gritstone Bio, Inc. with a value of $9.15M, Adverum Biotechnologies, Inc. with a value of $7.17M, and Passage Bio, Inc. with a value of $6.7M.

Examining the 13F form we can see an increase of $3.6M in the current position value, from $68.1M to 71.7M.

Versant Venture Management, LLC is based out at San Francisco, CA

Below you can find more details about Versant Venture Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $71.7 Million
Healthcare: $71.7 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 7
  • Current Value $71.7 Million
  • Prior Value $68.1 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 03, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Versant Venture Management, LLC Portfolio

Follow Versant Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Versant Venture Management, LLC with notifications on news.